Delivery Order SPE2DB22D1103-SPE2DB25FH3D0
Award Date 9/24/25
Potential Completion Date 10/16/25
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,119.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for INQOVI 35 mg–100 mg tablets (5 units) on August 22, 2025, with completion targeted for September 15, 2025. This non-set-aside award represents a child order under AmerisourceBergen's broader indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $5,119.36 to AmerisourceBergen Drug Corp for INQOVI 35 mg-100 mg tablets on August 29, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, non-set-aside contract utilizing firm fixed pricing was issued under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a $5,119.36 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for INQOVI 35 mg-100 mg tablets (5-count units), with performance expected in Conshohocken, Pennsylvania by September 10, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The IDC serves...
- The Defense Logistics Agency awarded a $5,119.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for INQOVI 35 mg-100 mg tablets in a 5-count unit pack on September 22, 2025, with completion scheduled for October 14, 2025. This non-competitive delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement...
- This delivery order, issued by the Defense Logistics Agency (DLA) on July 23, 2025, awards AmerisourceBergen Drug Corp $5,119.36 for the supply of INQOVI 35 mg-100 mg tablets in quantities of 5 units. The contract, which is non-set-aside and competitively awarded, represents a firm fixed-price delivery order with a completion date of August 13, 2025, and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564134395! INQOVI 35 MG-100 MG TABLET UU 5S. The award, valued at $4,830.47, has an ultimate completion date of April 22, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, specializes in supplying pharmaceuticals, medical supplies, and related distribution services to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide INQOVI 35 MG-100 MG tablets. The $4,830.47 contract has a completion date of March 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of INQOVI 35 MG-100 MG tablets in unit dose packages of five. This competitively awarded, firm fixed-price delivery order has a ceiling value of $5,119.36 and an ultimate completion date of May 15, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INQOVI is a prescription...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $14,491.41 delivery order is for the supply of INQOVI 35 MG-100 MG tablets, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of May 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of INQOVI 35 MG-100 MG tablets. The contract has a ceiling value of $4,830.47 and a completion date of July 15, 2024. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation. Amerisourcebergen, through its Corporate Office Division, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...